Stock Picks: Two Tech Firms Face Different Expectations

Investors often rely on expert opinions to guide their choices. Two tech companies, C3ai and Plexus, recently received mixed reviews from analysts. C3ai, a company working on artificial intelligence software, saw its stock value drop to $10. 43 last Friday. Most experts suggest selling, with an average price target of $9. 67—about 8% below current levels. J. P. Morgan’s Brian Essex, a well-known tech analyst, stands by this cautious view. One firm even downgraded the stock further, showing little confidence in its short-term growth.Plexus, on the other hand, specializes in electronics manufacturing. Its shares traded at $273. 01 recently, and analysts remain bullish. Benchmark Co. ’s David Williams set a $310 target, a nearly 14% increase. Even among peers, Plexus is seen as a strong buy, with a consensus price target of $287. 50. This optimism contrasts sharply with C3ai’s struggles, raising questions about market trends in AI versus hardware sectors. What’s driving these differing opinions? For C3ai, revenue growth has lagged behind expectations, while Plexus benefits from steady demand in tech supply chains. Investors must weigh these factors carefully before making decisions.